Last updated: 31 August 2020 at 4:50pm EST

E Premkumar Reddy Net Worth




The estimated Net Worth of E Premkumar Reddy is at least 159 千$ dollars as of 27 August 2020. E Reddy owns over 527,863 units of Onconova Therapeutics Inc stock worth over 16,683$ and over the last 11 years E sold ONTX stock worth over 142,523$.

E Reddy ONTX stock SEC Form 4 insiders trading

E has made over 8 trades of the Onconova Therapeutics Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently E sold 527,863 units of ONTX stock worth 142,523$ on 27 August 2020.

The largest trade E's ever made was selling 527,863 units of Onconova Therapeutics Inc stock on 27 August 2020 worth over 142,523$. On average, E trades about 64,844 units every 136 days since 2013. As of 27 August 2020 E still owns at least 16,683 units of Onconova Therapeutics Inc stock.

You can see the complete history of E Reddy stock trades at the bottom of the page.



What's E Reddy's mailing address?

E's mailing address filed with the SEC is C/O ONCONOVA THERAPEUTICS, INC., 375 PHEASANT RUN, NEWTOWN, PA, 18940.

Insiders trading at Onconova Therapeutics Inc

Over the last 12 years, insiders at Onconova Therapeutics Inc have traded over 1,631,795$ worth of Onconova Therapeutics Inc stock and bought 27,892,613 units worth 51,994,589$ . The most active insiders traders include Capital, Llc Armistice Capi...Capital Management, Llc 683Capital Partners L P Tyndall. On average, Onconova Therapeutics Inc executives and independent directors trade stock every 40 days with the average trade being worth of 294,478$. The most recent stock trade was executed by Mark Patrick Guerin on 13 March 2024, trading 8,666 units of ONTX stock currently worth 8,666$.



What does Onconova Therapeutics Inc do?

onconova therapeutics, inc. (nasdaq: ontx) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. using a proprietary chemistry platform, onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. onconova has three product candidates in clinical trials and six active pre-clinical programs. onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.



What does Onconova Therapeutics Inc's logo look like?

Onconova Therapeutics Inc logo

Complete history of E Reddy stock trades at Onconova Therapeutics Inc

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
27 Aug 2020 E Premkumar Reddy
ディレクター
販売 527,863 0.27$ 142,523$
27 Aug 2020
16,683
25 Nov 2019 E Premkumar Reddy
ディレクター
購入する 500,000 0.20$ 100,000$
25 Nov 2019
544,546
26 Apr 2017 E Premkumar Reddy
ディレクター
購入する 119,048 2.10$ 250,001$
26 Apr 2017
385,832
2 May 2014 E Premkumar Reddy
ディレクター
オプション行使 27,084 1.33$ 36,022$
2 May 2014
1,337,838
19 Dec 2013 E Premkumar Reddy
ディレクター
オプション行使 32,036 1.33$ 42,608$
19 Dec 2013
1,310,754
18 Nov 2013 E Premkumar Reddy
ディレクター
購入する 5,000 12.10$ 60,500$
18 Nov 2013
1,278,718
30 Jul 2013 E Premkumar Reddy
ディレクター
購入する 20,000 15.00$ 300,000$
30 Jul 2013
1,272,718
25 Jul 2013 E Premkumar Reddy
ディレクター
購入する 1,000 22.72$ 22,720$
25 Jul 2013
1,273,718


Onconova Therapeutics Inc executives and stock owners

Onconova Therapeutics Inc executives and other stock owners filed with the SEC include: